Annovis Weighted Average Shares vs Net Income Common Stock Analysis

ANVS
 Stock
  

USD 12.20  0.93  8.25%   

Annovis Bio financial indicator trend analysis is way more than just evaluating Annovis Bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Annovis Bio is a good investment. Please check the relationship between Annovis Bio Weighted Average Shares and its Net Income Common Stock accounts. Please continue to Trending Equities.

Weighted Average Shares vs Net Income Common Stock

Weighted Average Shares vs Net Income Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Annovis Bio Weighted Average Shares account and Net Income Common Stock. At this time, the significance of the direction appears to have pay attention.
The correlation between Annovis Bio's Weighted Average Shares and Net Income Common Stock is -0.92. Overlapping area represents the amount of variation of Weighted Average Shares that can explain the historical movement of Net Income Common Stock in the same time period over historical financial statements of Annovis Bio, assuming nothing else is changed. The correlation between historical values of Annovis Bio's Weighted Average Shares and Net Income Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Weighted Average Shares of Annovis Bio are associated (or correlated) with its Net Income Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income Common Stock has no effect on the direction of Weighted Average Shares i.e., Annovis Bio's Weighted Average Shares and Net Income Common Stock go up and down completely randomly.

Correlation Coefficient

-0.92
Relationship DirectionNegative 
Relationship StrengthSignificant

Weighted Average Shares

The weighted average number of shares or units issued and outstanding that are used by the company to calculate [EPS]; determined based on the timing of issuance of shares or units in the period.

Net Income Common Stock

The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends.
Most indicators from Annovis Bio fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Annovis Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please continue to Trending Equities.As of 06/27/2022, Issuance Purchase of Equity Shares is likely to grow to about 50.4 M, while Selling General and Administrative Expense is likely to drop slightly above 4.8 M.

Annovis Bio fundamental ratios Correlations

Annovis Bio Account Relationship Matchups

Be your own money manager

Our tools can tell you how much better you can do entering a position in Annovis Bio without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Breakdown Now

   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Module
Please continue to Trending Equities. Note that the Annovis Bio information on this page should be used as a complementary analysis to other Annovis Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Annovis Stock analysis

When running Annovis Bio price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Is Annovis Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
92 M
Return On Assets
-0.44
Return On Equity
-0.74
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.